DK505583D0 - Fremgangsmade til fremstilling af thiophen-2-carboxylsyrederivater - Google Patents

Fremgangsmade til fremstilling af thiophen-2-carboxylsyrederivater

Info

Publication number
DK505583D0
DK505583D0 DK5055/83A DK505583A DK505583D0 DK 505583 D0 DK505583 D0 DK 505583D0 DK 5055/83 A DK5055/83 A DK 5055/83A DK 505583 A DK505583 A DK 505583A DK 505583 D0 DK505583 D0 DK 505583D0
Authority
DK
Denmark
Prior art keywords
thiophen
preparing
procedure
carboxylic acid
acid derivatives
Prior art date
Application number
DK5055/83A
Other languages
English (en)
Other versions
DK162645C (da
DK505583A (da
DK162645B (da
Inventor
Dieter Binder
Christian Noe
Original Assignee
Laevosan Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan Gmbh & Co Kg filed Critical Laevosan Gmbh & Co Kg
Publication of DK505583D0 publication Critical patent/DK505583D0/da
Publication of DK505583A publication Critical patent/DK505583A/da
Publication of DK162645B publication Critical patent/DK162645B/da
Application granted granted Critical
Publication of DK162645C publication Critical patent/DK162645C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
DK505583A 1982-11-05 1983-11-04 Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater DK162645C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0404182A AT376436B (de) 1982-11-05 1982-11-05 Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
AT404182 1982-11-05

Publications (4)

Publication Number Publication Date
DK505583D0 true DK505583D0 (da) 1983-11-04
DK505583A DK505583A (da) 1984-05-06
DK162645B DK162645B (da) 1991-11-25
DK162645C DK162645C (da) 1992-04-13

Family

ID=3558851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK505583A DK162645C (da) 1982-11-05 1983-11-04 Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater

Country Status (9)

Country Link
US (1) US4590203A (da)
EP (1) EP0109381B1 (da)
JP (1) JPS59108780A (da)
AT (1) AT376436B (da)
CA (1) CA1209576A (da)
DE (1) DE3364995D1 (da)
DK (1) DK162645C (da)
FI (1) FI75565C (da)
PT (1) PT77613B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE57925T1 (de) * 1987-04-03 1990-11-15 Cl Pharma Neue 2-thienyloxyessigsaeurederivate, ein verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
AT395425B (de) * 1991-04-04 1992-12-28 Laevosan Gmbh & Co Kg Neue thiophen-2-carbonsaeurederivate und verfahren zu deren herstellung
US5608082A (en) * 1994-07-28 1997-03-04 Agouron Pharmaceuticals, Inc. Compounds useful as antiproliferative agents and GARFT inhibitors
US5527920A (en) * 1994-11-18 1996-06-18 Singh; Inder P. Economical manufacturing process for 1,2,3-triazoles
US6545163B1 (en) * 1995-10-02 2003-04-08 Napp Technologies Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers
JP5578809B2 (ja) * 2008-06-26 2014-08-27 石原産業株式会社 3−メチル−2−チオフェンカルボン酸の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186990A (en) * 1961-08-22 1965-06-01 Union Carbide Corp 2-thienylmethylmercaptoamidine hydrochlorides and cyclic derivatives thereof
SE339235B (da) * 1965-06-01 1971-10-04 Haessle Ab
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
JPS5734275B2 (da) * 1973-07-30 1982-07-22
US4087536A (en) * 1976-05-04 1978-05-02 The Dow Chemical Company Method for the use of thienylvinylimidazoles as anthelmintics
DK151884C (da) * 1979-03-07 1988-06-13 Pfizer Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DE2950064A1 (de) * 1979-12-13 1981-06-19 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 3-hydroxythiophen-2-carbonsaeure und -estern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE2951601A1 (de) * 1979-12-21 1981-07-02 C.H. Boehringer Sohn, 6507 Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
FI75565C (fi) 1988-07-11
ATA404182A (de) 1984-04-15
US4590203A (en) 1986-05-20
EP0109381B1 (de) 1986-07-30
EP0109381A1 (de) 1984-05-23
FI834023A (fi) 1984-05-06
FI75565B (fi) 1988-03-31
JPH0210157B2 (da) 1990-03-06
DE3364995D1 (en) 1986-09-04
PT77613B (de) 1986-03-19
AT376436B (de) 1984-11-26
CA1209576A (en) 1986-08-12
DK162645C (da) 1992-04-13
JPS59108780A (ja) 1984-06-23
DK505583A (da) 1984-05-06
DK162645B (da) 1991-11-25
PT77613A (de) 1983-12-01
FI834023A0 (fi) 1983-11-02

Similar Documents

Publication Publication Date Title
DK470583A (da) Fremgangsmaade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
DK144783A (da) Fremgangsmaade til fremstilling af cycloalka(c)pyrrol-carboxylsyrederivater
DK336783D0 (da) Fremgangsmade til fremstilling af methylendiphosphonsyrederivater
DK225184A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycinsyre
DK492783D0 (da) Fremgangsmade til fremstilling af 3-aryl-5-pyrazol-derivater
DK95483D0 (da) Fremgangsmade til fremstilling af tetrahydropyranderivater
DK155783D0 (da) Fremgangsmade til fremstilling af phenoxyalkylcarboxylsyrederivater
DK166087C (da) Fremgangsmaade til fremstilling af oe(3-amino-3-carboxy)-propyl-1aaphosphinsyrederivater
DK103683D0 (da) Fremgangsmade til fremstilling af 2-keto-l-gulonsyre
DK103583D0 (da) Fremgangsmade til fremstilling af 2-keto-l-gulonsyre
DK153583A (da) Fremgangsmaade til fremstilling af substituerede penemderivater
DK489381A (da) Fremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK501781A (da) Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK505583D0 (da) Fremgangsmade til fremstilling af thiophen-2-carboxylsyrederivater
DK71783D0 (da) Fremgangsmade til fremstilling af pyrimidonderivater
DK371981A (da) Fremgangsmaade til fremstilling af aminoacetonitrilderivater
DK231581A (da) Fremgangsmaade til fremstilling af phenoxyaminopropanolderivater
DK154554C (da) Fremgangsmaade til fremstilling af alfa-methyl-carbazol-2-eddikesyrederivater
DK57381A (da) Fremgansmaade til fremstilling af bifenyloxypropionsyrederivater
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
DK228583A (da) Fremgangsmaade til fremstilling af 5-oxo-2-pyrrolidinpropansyrederivater
DK57881A (da) Fremgangsmaade til fremstilling af benzylinderivater
DK139983D0 (da) Fremgangsmade til fremstilling af 2-thiopheneddikesyrederivater
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer

Legal Events

Date Code Title Description
PBP Patent lapsed